Q2 2023 · 13F-HR
Lion Point Capital, LPholdings as filed
Filed 2023-08-14 · accession 0001013594-23-000689
$221.3M
Reported value
30
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 816850101 | SMTC | SEMTECH CORP | $63.6M | 28.8% | 2,500,000 | CALL | SOLE |
| 816850101 | SMTC | SEMTECH CORP | $62.4M | 28.2% | 2,452,855 | Common | SOLE |
| 56854Q200 | MRNS* | MARINUS PHARMACEUTICALS INC | $24.5M | 11.1% | 2,257,521 | Common | SOLE |
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $22.2M | 10.0% | 50,000 | PUT | SOLE |
| 674215207 | CHRD | CHORD ENERGY CORPORATION | $15.7M | 7.12% | 102,403 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $5.2M | 2.34% | 1,526,667 | Common | SOLE |
| 12122L101 | 0LS | BURGERFI INTERNATIONAL INC | $4.3M | 1.95% | 2,745,938 | Common | SOLE |
| 81750R102 | MCRB1EUR | SERES THERAPEUTICS INC | $3.3M | 1.50% | 691,803 | Common | SOLE |
| 266605500 | DC8A | DURECT CORP | $3.0M | 1.35% | 601,664 | Common | SOLE |
| 07134L107 | BATL | BATTALION OIL CORP | $2.2M | 0.98% | 380,891 | Common | SOLE |
| G5269C101 | — | KINIKSA PHARMACEUTICALS LTD | $1.8M | 0.83% | 130,691 | Common | SOLE |
| 09609G100 | — | BLUEBIRD BIO INC | $1.7M | 0.79% | 531,256 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $1.3M | 0.58% | 450,207 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $1.1M | 0.51% | 109,898 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $1.1M | 0.51% | 111,667 | Common | SOLE |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC | $1.1M | 0.49% | 99,425 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $1.1M | 0.48% | 50,335 | Common | SOLE |
| 31447P100 | FENC | FENNEC PHARMACEUTICALS INC | $971,300 | 0.44% | 110,000 | Common | SOLE |
| G46188101 | HZNPN | HORIZON THERAPEUTICS PUB L | $761,090 | 0.34% | 7,400 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $722,085 | 0.33% | 34,500 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $698,490 | 0.32% | 27,000 | Common | SOLE |
| 00032Q104 | WHWK | AADI BIOSCIENCE INC | $563,773 | 0.25% | 82,423 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $480,340 | 0.22% | 146,000 | CALL | SOLE |
| 68622D106 | AACQGBP | ORIGIN MATERIALS INC | $426,000 | 0.19% | 100,000 | Common | SOLE |
| 41358P106 | — | HARPOON THERAPEUTICS INC | $324,125 | 0.15% | 456,514 | Common | SOLE |
| 12122L119 | — | BURGERFI INTERNATIONAL INC | $265,638 | 0.12% | 2,083,438 | CALL | SOLE |
| 55028X109 | 4NX1 | LUMOS PHARMA INC | $258,558 | 0.12% | 78,351 | Common | SOLE |
| 594918104 | MSFT | MICROSOFT CORP | $34,054 | 0.02% | 100 | Common | SOLE |
| 02079K107 | GOOG | ALPHABET INC | $12,097 | 0.01% | 100 | Common | SOLE |
| 69327R101 | — | PDC ENERGY INC | $7,114 | 0.00% | 100 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.